FDA Investigator: Tamil Arasu
- Tamil Arasu first started conducting FDA inspections in 2014, with the last inspection in 2024. Over that time, Tamil Arasu has conducted 88 inspections at 82 companies across 84 sites.
Get Tamil Arasu's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 SRI Krishna Pharmaceuticals - Unit I | Sep 2023
Available Now - $199
Tamil Arasu
Human Drugs Form 483
FDA 483 ImClone Systems, . d.b.a. Eli Lilly and | Aug 2020
Available Now - $199
Tamil Arasu
Human Drug Form 483
FDA 483 BOEHRINGER INGELHEIM PROMECO . de C.V | Dec 2019
Available Now - $199
Tamil Arasu
Human Drug Form 483
FDA 483 ImClone Systems, . d.b.a. Eli Lilly and | Nov 2019
Available Now - $199
Tamil Arasu
Human Drug Form 483
FDA 483 Aurobindo Pharma, Polepally, Mahaboob Nagar | 2019
Available Now - $199
Tamil Arasu
Human Drug Form 483
FDA 483 Bristol-Myers Squibb ., Pharmaceutical Resear | 2019
Available Now - $199
Tamil Arasu
Human Drug Form 483
FDA 483 Specialty Electronic Materials Switzerland | 2019
Available Now - $199
Tamil Arasu
Human Drug Form 483
FDA 483 Tris Pharma, Monmouth Junction | January 2019
Available Now - $199
Tamil Arasu
Human Drug Form 483
FDA 483 Chemtrade Solutions, Midlothian | August 2015
Available Now - $199
Tamil Arasu
Human Drug Form 483
FDA 483 Cipla Limited, Vasco Da Gama | 2024
Out-of-stock
Tamil Arasu
Human Drugs Form 483
FDA 483 Dr. Reddy's Laboratories Limited CTO VI, Pydibhimavaram | 2024
Out-of-stock
Tamil Arasu
Human Drugs Form 483
FDA 483 Norbrook Laboratories Limited, Newry | 2024
Out-of-stock
Tamil Arasu
Animal Drugs & Feeds Form 483
FDA 483 Jubilant Generics Limited, Roorkee | 2024
Out-of-stock
Tamil Arasu
Human Drugs Form 483
FDA 483 Intas Pharmaceuticals Ltd., Selaqui | 2024
Out-of-stock
Tamil Arasu
Human Drugs Form 483
FDA 483 Sicor de Mexico S.A. de C.V., Lerma De Villada | 2023
Out-of-stock
Tamil Arasu
Human Drugs Form 483
FDA 483 Somerset Therapeutics Limited, Bengaluru | 2023
Out-of-stock
Tamil Arasu
Human Drugs Form 483
FDA 483 Hetero Labs Limited, Sangareddy | 2023
Out-of-stock
Tamil Arasu
Human Drugs Form 483
FDA 483 MSN PHARMACEUTICALS INC, Piscataway | 2021
Out-of-stock
Tamil Arasu
Human Drug Form 483
FDA 483 NATCO Pharma Limited, Rangareddy | 2020
Out-of-stock
Tamil Arasu
Human Drug Form 483
FDA 483 Signa S.A. de C.V., Toluca De Lerdo | 2019
Out-of-stock
Tamil Arasu
Human Drug Form 483
FDA 483 Sicor de Mexico S.A. de C.V., Lerma De Villada | 2019
Out-of-stock
Tamil Arasu
Human Drug Form 483
Co-Investigators (42)
- Joseph A. Piechocki, FDA Investigator
- Eileen A. Liu, FDA Investigator
- Tran, Khoa Nathan V, FDA Investigator
- Jeffrey P. Raimondi, FDA Investigator
- Patty P. Kaewussdangkul, FDA Investigator
- Jose M. Cayuela, FDA Investigator
- Alan M. Barker, FDA Investigator
- Cynthia Jim, FDA Investigator
- Pratik S. Upadhyay, FDA Investigator
- Rose L. Jean-Mary, FDA Investigator
- Frederick Razzaghi, FDA Investigator
- Ko U. Min, FDA Investigator
- Zhaoyang Meng, FDA Investigator
- Guerlain Ulysse, FDA Investigator
- Jogy George, FDA Investigator
- Emmanuel J. Ramos, FDA Investigator
- Sean R. Marcsisin, FDA Investigator
- Thomas J. Arista, FDA Investigator
- John P. Mistler, FDA Investigator
- Russell J. Glapion, FDA Investigator
- Jose O. Hernandez, FDA Investigator
- Vicky L. Cruz, FDA Investigator
- Atul Agrawal, FDA Investigator
- Marcellinus D. Dordunoo, FDA Investigator
- James R. Birkenstamm, FDA Investigator
- Yvins Dezan, FDA Investigator
- William R. Chang, FDA Investigator
- Unnee Ranjan, FDA Investigator
- Dipesh K. Shah, FDA Investigator
- Nancy M. Espinal, FDA Investigator
- Darren S. Brown, FDA Investigator
- Niketa Patel, FDA Investigator
- Ashar P. Parikh, FDA Investigator
- Adetutu M. Gidado, FDA Investigator
- Saleem A. Akhtar, FDA Investigator
- Shelby N. Marler, FDA Investigator
- Michael R. Klapal, FDA Investigator
- Liatte Krueger, FDA Investigator
- Dhaval H. Patel, FDA Investigator
- Jo-Ann C. Declement, FDA Investigator
- Jessica M. Monteiro, FDA Investigator
- Kimberley A. Ricketts, FDA Investigator